Holen Sie sich die Stockscreener-App
3.89
2.51%
-0.09
Schlusskurs vom Vortag:
$3.98
Offen:
$4.01
24-Stunden-Volumen:
30,323
Relative Volume:
0.32
Marktkapitalisierung:
$64.04M
Einnahmen:
$27.48M
Nettoeinkommen (Verlust:
$-7.72M
KGV:
-8.2293
EPS:
-0.4727
Netto-Cashflow:
$332.00K
1W Leistung:
-8.71%
1M Leistung:
+0.52%
6M Leistung:
+22.01%
1J Leistung:
-12.42%
1-Tages-Spanne:
$3.85
$4.0255
1-Wochen-Bereich:
$3.85
$4.44
52-Wochen-Spanne:
$3.03
$5.92
Sensus Healthcare Inc Stock (SRTS) Company Profile
Firmenname
Sensus Healthcare Inc
Sektor
Branche
Telefon
561-922-5808
Adresse
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
3.89 | 65.52M | 27.48M | -7.72M | 332.00K | -0.4727 |
|
ABT
Abbott Laboratories
|
107.80 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
335.84 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.85 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.70 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.88 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-01-31 | Eingeleitet | Lake Street | Buy |
| 2024-11-15 | Bestätigt | Maxim Group | Buy |
| 2021-02-26 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-12-16 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2020-08-10 | Hochstufung | Alliance Global Partners | Neutral → Buy |
| 2020-02-14 | Hochstufung | Alliance Global Partners | Neutral → Buy |
| 2019-11-07 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2019-01-29 | Herabstufung | Northland Capital | Market Perform → Under Perform |
| 2018-09-26 | Eingeleitet | B. Riley FBR | Buy |
| 2017-11-03 | Bestätigt | Maxim Group | Buy |
| 2017-06-06 | Eingeleitet | Maxim Group | Buy |
| 2016-08-08 | Eingeleitet | Northland Capital | Outperform |
Alle ansehen
Sensus Healthcare Inc Aktie (SRTS) Neueste Nachrichten
Why The Sensus Healthcare (SRTS) Story Is Shifting As Targets Diverge On 2026 Expectations - Yahoo Finance
Institution Moves: What are the future prospects of Sensus Healthcare IncTrade Analysis Report & Accurate Buy Signal Notifications - baoquankhu1.vn
Sensus Healthcare (NASDAQ:SRTS) Now Covered by Analysts at Alliance Global Partners - MarketBeat
Aug Levels: Is Sensus Healthcare Inc forming higher highs and higher lowsJuly 2025 Macro Moves & Breakout Confirmation Alerts - baoquankhu1.vn
Sensus Healthcare Inc. (SRTS) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Sensus Healthcare 2025 10-K: Revenue $27.48M, EPS $(0.47) - TradingView
Sensus Healthcare (NASDAQ: SRTS) posts 2025 loss and outlines growth strategy - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Average Rating of "Hold" by Analysts - MarketBeat
Merger Talk: Is Sensus Healthcare Inc stock risky to hold now2025 AllTime Highs & High Conviction Buy Zone Alerts - baoquankhu1.vn
Aug Fed Impact: What are the future prospects of Sensus Healthcare Inc2025 Technical Patterns & Smart Money Movement Tracker - baoquankhu1.vn
Valuation Update: What are the future prospects of Sensus Healthcare IncJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn
Sensus Healthcare launches cloud software for radiotherapy systems By Investing.com - Investing.com Australia
Insider Buying: Eric Sachetta Acquires Additional Shares of Sens - GuruFocus
Sachetta Eric buys Sensus Healthcare (SRTS) shares worth $7,620 By Investing.com - Investing.com Nigeria
Sachetta Eric buys Sensus Healthcare (SRTS) shares worth $7,620 - Investing.com
Director Eric Sachetta buys Sensus Healthcare (SRTS) shares in open market - Stock Titan
Sensus Healthcare launches cloud software for radiotherapy systems - Investing.com
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base - marketscreener.com
Is Sensus Healthcare Inc. stock affected by interest rate hikes2025 Key Highlights & Expert Approved Trade Ideas - mfd.ru
Block Trades: Is Telephone and Data Systems Inc stock influenced by commodity pricesEarnings Beat & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Sensus Healthcare launches financing service for SRT systems - Investing.com India
Why Sensus Healthcare Inc. stock is rated strong buyQuarterly Portfolio Summary & Technical Buy Zone Confirmation - mfd.ru
Sensus Healthcare launches financing service for SRT systems By Investing.com - Investing.com Nigeria
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology - BioSpace
SRTS: Maxim Group Lowers Price Target, Maintains Buy Rating | SR - GuruFocus
Sensus Healthcare, Inc. (NASDAQ:SRTS) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
Sensus Healthcare, Inc. (NASDAQ:SRTS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance
Can Sensus Healthcare Inc. stock sustain institutional interest2025 Key Lessons & Real-Time Stock Price Movement Reports - mfd.ru
SRTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Wall Street Zen Downgrades Sensus Healthcare (NASDAQ:SRTS) to Sell - Defense World
SRTS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Sensus Healthcare Bets on 2026 Reimbursement Rebound - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2025 Earnings Call Transcript - Insider Monkey
Is Sensus Healthcare Inc. stock risky to hold nowJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - mfd.ru
Sensus Healthcare, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Sensus Healthcare Inc (SRTS) Q4 2025 Earnings Call Highlights: N - GuruFocus
Sensus Healthcare Q4 Earnings Call Highlights - MarketBeat
Sensus Healthcare SRTS Q4 2025 Earnings Transcript - AOL.com
SRTS: Reimbursement clarity and international growth set the stage for profitability in 2026 - TradingView
Earnings call transcript: Sensus Healthcare’s Q4 2025 earnings miss forecasts By Investing.com - Investing.com India
Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Estimates By $0.10 EPS - MarketBeat
Earnings call transcript: Sensus Healthcare’s Q4 2025 earnings miss forecasts - Investing.com
Sensus Healthcare (SRTS): Q4 Revenue Decline and 2026 Growth Pro - GuruFocus
SRTS: New CMS codes and strong cash position set the stage for growth and profitability in 2026 - TradingView
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer - marketscreener.com
Sensus Healthcare (NASDAQ:SRTS) shareholders have endured a 36% loss from investing in the stock three years ago - Yahoo Finance
Sensus Healthcare Inc (SRTS) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Can Sensus Healthcare Inc. stock continue upward trendWeekly Trading Summary & Short-Term Trading Opportunity Alerts - mfd.ru
Finanzdaten der Sensus Healthcare Inc-Aktie (SRTS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sensus Healthcare Inc-Aktie (SRTS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Nov 21 '25 |
Buy |
3.93 |
7,000 |
27,510 |
140,113 |
| Sachetta Eric | Director |
Nov 13 '25 |
Buy |
4.50 |
2,500 |
11,250 |
133,113 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Nov 18 '25 |
Buy |
4.03 |
25,000 |
100,750 |
1,200,293 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 18 '25 |
Buy |
3.80 |
1,000 |
3,800 |
118,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 11 '25 |
Buy |
4.26 |
1,000 |
4,260 |
117,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Aug 13 '25 |
Buy |
3.37 |
1,000 |
3,370 |
116,839 |
0.70%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):